People news

Share this article:
Acceleron Pharma, a biopharmaceutical company developing novel therapeutics that modulate the growth of tissues including bone and muscle, announced that John Knopf, Ph.D., has been named as CEO. Knopf, a founder of Acceleron, has served as the EVP of corporate development and recently, as president, before being unanimously elected by the board as CEO. Prior to co-founding Acceleron, Knopf was formerly site head of the Wyeth Research facilities in Cambridge, MA and VP of metabolic and respiratory disease until 2002. Knopf was also a key scientist at Genetics Institute from 1982 to 1998, where he participated in the development of pioneering biopharmaceutical products and helped establish Genetics Institute as a premier biopharmaceutical company. He also established a structure-based small molecule discovery group at Genetics Institute.
Share this article:
You must be a registered member of MMM to post a comment.

Next Article in People Moves

Email Newsletters

MM&M Future Leaders

Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 


Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in People Moves

Monday Moves: September 29

Promotions and hires for agencies and manufacturers

Monday Moves—July 21, 2014

Hires and promotions for Manufacturers, Agencies and Media